1. Home
  2. Labeler Index
  3. Auromedics Pharma Llc
  4. 55150-191
  5. Product Images: Ibandronate Sodium

Product Images Ibandronate Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Ibandronate Sodium NDC 55150-191 by Auromedics Pharma Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 Mean Percent Change (95% Confidence Interval) from Baseline in Lumbar Spine BMD at One Year in Patients Treated with Ibandronate 2.5 mg Daily Oral Tablet or Ibandronate Sodium Injection 3 mg Once Every 3 Months - ibandronate fig1

Figure 1 Mean Percent Change (95% Confidence Interval) from Baseline in Lumbar Spine BMD at One Year in Patients Treated with Ibandronate 2.5 mg Daily Oral Tablet or Ibandronate Sodium Injection 3 mg Once Every 3 Months - ibandronate fig1

This is a medical report on treatment options for lumbar spine bone mineral density (BMD) increase. It suggests two dosage options- 2.5 mg daily or 3mg every 3 months. The efficacy of the treatment options is compared, and the 3mg every 3 months dose appears to be more beneficial in increasing BMD. The comparison between the two doses is statistically significant with a p-value of less than 0.001.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 3 mg per 3 mL (1 mg / mL) - Prefilled Syringe Label - ibandronate fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 3 mg per 3 mL (1 mg / mL) - Prefilled Syringe Label - ibandronate fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 3 mg per 3 mL (1 mg / mL) - Prefilled Syringe Blister Label - ibandronate fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 3 mg per 3 mL (1 mg / mL) - Prefilled Syringe Blister Label - ibandronate fig3

This is a description of a medication called Ibandronate Sodium, which is prescribed and distributed under FDA regulations. It is a sterile solution for injection, to be administered intravenously, and contains 3 milligrams per 3 milliliters, with a concentration of 1 milligram per milliliter. The drug is manufactured in India, and is distributed in the US by AuroMedics Pharma LLC.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 3 mg per 3 mL (1 mg / mL) - Prefilled Syringe-Carton - ibandronate fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 3 mg per 3 mL (1 mg / mL) - Prefilled Syringe-Carton - ibandronate fig4

This is a description of a medication called Ibandronate Sodium. It is a single-dose prefilled syringe containing 3 mg per 3 mL (1 mg / mL) intended for intravenous use only. The pharmacist is instructed to dispense the enclosed medication guide to each patient. The usual dosage is for intravenous administration over a period of 15 to 30 seconds. The medication is distributed by AuroMedics Pharma LLC and made in India. The storage temperature recommended is between 20°C and 25°C (68°F to 77°F). The NDC code for this medication is 55150-191-63.*

ibandronate fig5

ibandronate fig5

This is a pharmaceutical product containing Ibandronate Sodium in the form of a single-dose prefilled syringe, injection and needle used for intravenous administration. Each carton contains one syringe of 3 mg Ibandronate Sodium (1 mg/mL) and sterile, to be administered using the provided needle. The product comes with a medication guide recommended to be given to each patient. It is for prescription use only. The manufacturer is NAL'ROMEDICS, and the product is coded TSDRUGS/132010, with an NDC of 55150-191-83.*

Ibandronate Sodium Chemical Structure - ibandronate str

Ibandronate Sodium Chemical Structure - ibandronate str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.